AVXL
Price
$12.13
Change
-$0.61 (-4.79%)
Updated
Jul 25 closing price
Capitalization
1.04B
16 days until earnings call
PLRX
Price
$1.57
Change
-$0.02 (-1.26%)
Updated
Jul 25 closing price
Capitalization
96.38M
15 days until earnings call
Interact to see
Advertisement

AVXL vs PLRX

Header iconAVXL vs PLRX Comparison
Open Charts AVXL vs PLRXBanner chart's image
Anavex Life Sciences
Price$12.13
Change-$0.61 (-4.79%)
Volume$1.27M
Capitalization1.04B
Pliant Therapeutics
Price$1.57
Change-$0.02 (-1.26%)
Volume$560.49K
Capitalization96.38M
AVXL vs PLRX Comparison Chart in %
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. PLRX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and PLRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AVXL: $12.13 vs. PLRX: $1.57)
Brand notoriety: AVXL and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 125% vs. PLRX: 42%
Market capitalization -- AVXL: $1.04B vs. PLRX: $96.38M
AVXL [@Biotechnology] is valued at $1.04B. PLRX’s [@Biotechnology] market capitalization is $96.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, AVXL is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 5 bullish TA indicator(s).

  • AVXL’s TA Score: 4 bullish, 4 bearish.
  • PLRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than AVXL.

Price Growth

AVXL (@Biotechnology) experienced а +10.47% price change this week, while PLRX (@Biotechnology) price change was +9.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

AVXL is expected to report earnings on Aug 12, 2025.

PLRX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($1.04B) has a higher market cap than PLRX($96.4M). AVXL YTD gains are higher at: 12.942 vs. PLRX (-88.079). AVXL has higher annual earnings (EBITDA): -45.65M vs. PLRX (-214.08M). PLRX has more cash in the bank: 306M vs. AVXL (116M). AVXL has less debt than PLRX: AVXL (88.2K) vs PLRX (60.2M). AVXL (0) and PLRX (0) have equivalent revenues.
AVXLPLRXAVXL / PLRX
Capitalization1.04B96.4M1,075%
EBITDA-45.65M-214.08M21%
Gain YTD12.942-88.079-15%
P/E RatioN/AN/A-
Revenue00-
Total Cash116M306M38%
Total Debt88.2K60.2M0%
FUNDAMENTALS RATINGS
AVXL: Fundamental Ratings
AVXL
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVXLPLRX
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 12 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
79%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKKVF1.20N/A
N/A
AKASTOR ASA ASA
SNNF10.98N/A
N/A
Seneca Finl Corp
SURVF0.88N/A
N/A
Suntec Real Estate Investment Trust
NTBP1250.00N/A
N/A
New Tripoli Bancorp, Inc.
PSZKY20.66-1.34
-6.09%
Powszechna Kasa Oszczednosci Bank Polski SA

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
-4.79%
PLRX - AVXL
47%
Loosely correlated
-1.26%
RXRX - AVXL
45%
Loosely correlated
+3.67%
TENX - AVXL
45%
Loosely correlated
-0.98%
MNMD - AVXL
41%
Loosely correlated
+0.41%
EYPT - AVXL
40%
Loosely correlated
-0.10%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with OCUL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-1.26%
OCUL - PLRX
41%
Loosely correlated
+2.43%
SRRK - PLRX
40%
Loosely correlated
N/A
LXRX - PLRX
40%
Loosely correlated
-2.65%
RIGL - PLRX
38%
Loosely correlated
-1.27%
CRGX - PLRX
37%
Loosely correlated
N/A
More